AWMS
GILD icon

Advocacy Wealth Management Services’s Gilead Sciences GILD Stock Holding History

Advocacy Wealth Management Services’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$31K Sell
462
-38
-8% -$2.27K 0.08% 144
2013
Q2 		$26K Buy
+500
New +$26.1K 0.1% 124

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Advocacy Wealth Management Services's GILD Position: Q3 2013 in Review

Advocacy Wealth Management Services reduced its Gilead Sciences (GILD) stake by 7.6% in Q3 2013, selling an estimated $2.27K and leaving 462 shares worth $31K. The position accounts for 0.08% of the portfolio, ranked #144.

Advocacy Wealth Management Services first reported a position in GILD in Q2 2013 and has held it in 2 quarters since. 982 funds tracked by Wall St. Rank hold GILD as of Q3 2013.

  • Advocacy Wealth Management Services held 462 shares of Gilead Sciences worth $31K as of Q3 2013.
  • Advocacy Wealth Management Services sold 38 Gilead Sciences shares in Q3 2013, an estimated $2.27K.
  • Gilead Sciences made up 0.08% of Advocacy Wealth Management Services's portfolio in Q3 2013, its #144 holding.
  • Advocacy Wealth Management Services first reported a position in Gilead Sciences in Q2 2013 and has held it in 2 quarters since.
  • 982 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2013.

Based on Advocacy Wealth Management Services's 13F filing for Q3 2013, filed 14 Nov 2013.